NexImmune, Inc. (NEXI)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0001 (-50.00%)
Aug 14, 2025, 8:00 PM EDT
NexImmune Employees
NexImmune had 6 employees as of December 31, 2023. The number of employees decreased by 44 or -88.00% compared to the previous year.
Employees
6
Change (1Y)
-44
Growth (1Y)
-88.00%
Revenue / Employee
n/a
Profits / Employee
-$3,436,142
Market Cap
279.00
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6 | -44 | -88.00% |
| Dec 31, 2022 | 50 | -24 | -32.43% |
| Dec 31, 2021 | 74 | 30 | 68.18% |
| Dec 31, 2020 | 44 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Silence Therapeutics | 116 |
| Longduoduo Company | 49 |
NexImmune News
- 1 year ago - NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 1 year ago - NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 1 year ago - Here's why penny stocks like GGE, NEXI, ALT, HCDI are pumping - Invezz
- 1 year ago - NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes - GlobeNewsWire
- 1 year ago - NexImmune Announces Presentations at The Society for Immunotherapy of Cancer's 38th Annual Meeting - GlobeNewsWire
- 1 year ago - NexImmune Announces 1-for-25 Reverse Stock Split - GlobeNewsWire
- 2 years ago - NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development Strategy - GlobeNewsWire
- 2 years ago - NexImmune Reports Second Quarter 2023 Financial Results and Provides Business Updates - GlobeNewsWire